Bimatoprost ( brand-named Latisse) is an FDA-approved daily treatment for eyelash hypotrichosis (inadequate or not enough lashes). This medication is a prostaglandin molecule in the form of an ophthalmic solution that was initially used to treat open-angle gluacoma (pressure inside the eyes). It was discovered to grow eyelashes in patients using these eyedrops and earned FDA approval in 2001 for eyelash growth after a series of successful clinical studies demonstrating efficacy and safety. While indicated for the upper eyelid lashes, it is used by some on both the upper and lower eyelid lashes. Here is what you should know about this medication before you buy and use it.
1. Bimatoprost 0.3% solution is a drug, which is why it has FDA approval. It has solid evidence in the scientific literature to supports its use to lengthen, thicken, and darken eyelash hairs.
2. It has a favorable safety profile in numerous clinical trials and well-studied and side effects.
3. It is only prescribed through a health care provider through a prescription and cannot be purchased over the counter.
4. If bimatoprost is stopped, there may be a reduction of the lashes that it was maintaining and the visible growth features will cease.
5. Common side effects (adverse events) include pruritus/itch, pigmentation of the eyelid or iris, nasopharyngitis, eyelid erythema/redness, and lowering of intraocular pressure.
In terms of SkinVestments, Latisse is a great investment supported by well-documented clinical and scientific evidence. Since it is a drug, it is not available over the counter and does require a prescription to obtain. While this may seem like a hassle, the FDA approval validates this treatment and also eliminates alot of the questions regarding its safety and efficacy. This is a solid investment that will cost about $100 to $150 for a 3 ml bottle, which may last up to six months. If you have hair loss conditions such as alopecia areata or have post-chemotherapy eyelash loss, Latisse may help grow your eyelashes. However, know that these are off-label uses and are beyond its cosmetic intended use.
Allergan Latisse Prescribing Product Information: http://www.allergan.com/assets/pdf/latisse_pi.pdf
Wirta D, et. al. Bimatoprost 0.03% for the Treatment of Eyelash Hypotrichosis: A Pooled Safety Analysis of Six Randomized, Double-masked Clinical Trials. J Clin Aesthet Dermatol. 2015 Jul;8(7):17-29.
Wirta D, et. al. Safety and Efficacy of Bimatoprost for Eyelash Growth in Postchemotherapy Subjects. J Clin Aesthet Dermatol. 2015 Apr;8(4):11-20.
Yoelin SG, et. al. A retrospective review and observational study of outcomes and safety of bimatoprost ophthalmic solution 0.03% for treating eyelash hypotrichosis. Dermatol Surg. 2014 Oct;40(10):1118-24.